Associate Director, International Market Access and Pricing, Immunology

The Associate Director, Pricing is the International pricing lead for RINVOQ . The role sets RINVOQ's International pricing strategy and preserves the integrity of RINVOQ's price across its indications and markets. It turns pricing analysis into clear guidance, robust business cases and accurate financial assumptions, and supports Area and affiliate teams in achieving broad, timely and sustainable patient access that reflects the value of RINVOQ. Key Responsibilities: Pricing Strategy and Guidance: • Develop and maintain International pricing guidance for RINVOQ (price corridors and launch and re-pricing recommendations) in line with brand strategy, the Integrated Access Strategy (IAS) and corporate objectives. • Apply the Strategic Pricing Framework to define the price potential of new indications and formulations, and recommend indication and country launch sequencing that maximizes International value. • Develop contracting guidance and access models that address payer objections and affordability concerns while preserving the integrity of RINVOQ's price. • Monitor International pricing policy and competitor pricing, and flag risks and opportunities for RINVOQ early. Business Cases and Pricing Governance: • Lead the development, review and challenge of RINVOQ pricing business cases from affiliates and Areas, ensuring each is analytically sound, compliant with International pricing governance and ready for decision. • Prepare and present business cases to the Executive Pricing Councils, with a clear recommendation, quantified financial impact, risks and mitigations. PVTO and IRP Analysis: • Build and run price-volume trade-off (PVTO) analyses to evaluate price and access scenarios, breakeven volumes and the net revenue impact of pricing decisions at market and International level. • Assess International Reference Pricing (IRP) implications of every proposed price change, launch price and confidential agreement. Quantify cross-country spill-over and recommend the sequencing and price levels that preserve the integrity of RINVOQ's price across International markets. • Work with International Pricing analysts to design, run and interpret IRP, PVTO and launch-sequencing models, and turn the outputs into clear recommendations for senior stakeholders. Plan and LRP: • Own the RINVOQ pricing assumptions in the annual Plan and Long Range Plan (LRP) process, including price evolution, launch timing, price erosion, IRP impact and risk and opportunity scenarios. • Collect, challenge and align pricing assumptions with Areas, affiliates and Finance, so that forecasts are consistent and explained. Cross-Functional Partnership: • Area and affiliates (primary partners): help key markets turn International pricing guidance into local outcomes, covering price potential, negotiation strategy, scenarios, fallback positions and objection handling for national and sub-national negotiations. • Therapy Area teams (primary partners): make sure the pricing position is reflected in the RINVOQ IAS and brand strategy, and that indication priorities reflect price potential. • HTA: align price potential with the expected HTA outcome and value story and assess the price implications of HTA evidence and comparator choices. • Finance: reconcile pricing inputs with Plan, LRP and business case financials, and agree the net revenue impact of pricing decisions. • Act as the internal subject matter expert on RINVOQ pricing, IRP and pricing analytics. Essential • Bachelor's degree in Finance, Economics, Health Economics, Statistics, Mathematics, Pharmacy or a related field. • At least 3 years' experience in pharmaceutical pricing, market access, health economics or commercial finance. • Strong quantitative and modelling skills, with experience b